SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2023-12-20 19:13
Tx date 2023-12-19 		$ACST
Acasti Pharma Inc. 		Kavuru, Vimal
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+10,000 vol 		37,017
Filed 2023-09-28 12:01
Tx date 2023-09-25 		$ACST
Acasti Pharma Inc. 		Kavuru, Vimal
4 - Director of Issuer
Holder: Shore Pharma LLC (Indirect Ownership)
Warrants Private Offering Sept 2023
11 - Acquisition or disposition carried out privately
+422,732 vol 		422,732
Filed 2023-09-28 12:00
Tx date 2021-08-27 		$ACST
Acasti Pharma Inc. 		Kavuru, Vimal
4 - Director of Issuer
Holder: Shore Pharma LLC (Indirect Ownership)
Warrants Private Offering Sept 2023
00 - Opening Balance-Initial SEDI Report
Filed 2023-09-28 12:00
Tx date 2023-09-25 		$ACST
Acasti Pharma Inc. 		Kavuru, Vimal
4 - Director of Issuer
Holder: Shore Pharma LLC (Indirect Ownership)
Common Shares (Actions de catégorie A)
11 - Acquisition or disposition carried out privately 		$1,250,001
+676,371 vol
$1.85 each 		1,188,076
Filed 2023-07-14 19:51
Tx date 2023-07-14 		$ACST
Acasti Pharma Inc. 		Kavuru, Vimal
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+12,500 vol 		27,017
Filed 2023-07-14 19:30
Tx date 2023-07-10 		$ACST
Acasti Pharma Inc. 		Kavuru, Vimal
4 - Director of Issuer
Holder: Shore Pharma LLC (Indirect Ownership)
Common Shares (Actions de catégorie A)
37 - Stock split or consolidation
+511,705 vol 		511,705
Filed 2023-07-14 19:30
Tx date 2023-07-10 		$ACST
Acasti Pharma Inc. 		Kavuru, Vimal
4 - Director of Issuer
Holder: Shore Pharma LLC (Indirect Ownership)
Common Shares (Actions de catégorie A)
37 - Stock split or consolidation
-3,070,229 vol 		0
Filed 2023-07-14 19:29
Tx date 2023-07-10 		$ACST
Acasti Pharma Inc. 		Kavuru, Vimal
4 - Director of Issuer
Holder: Kottayil Grace Pharma LLC (Control or Direction)
Common Shares (Actions de catégorie A)
37 - Stock split or consolidation
+124,344 vol 		124,344
Filed 2023-07-14 19:29
Tx date 2023-07-10 		$ACST
Acasti Pharma Inc. 		Kavuru, Vimal
4 - Director of Issuer
Holder: Kottayil Grace Pharma LLC (Control or Direction)
Common Shares (Actions de catégorie A)
37 - Stock split or consolidation
-746,064 vol 		0
Filed 2023-07-14 19:28
Tx date 2023-07-10 		$ACST
Acasti Pharma Inc. 		Kavuru, Vimal
4 - Director of Issuer
Direct Ownership
Options
37 - Stock split or consolidation
+14,517 vol 		14,517
Filed 2023-07-14 19:27
Tx date 2023-07-10 		$ACST
Acasti Pharma Inc. 		Kavuru, Vimal
4 - Director of Issuer
Direct Ownership
Options
37 - Stock split or consolidation
-87,100 vol 		0
Filed 2022-09-29 13:52
Tx date 2022-09-28 		$ACST
Acasti Pharma Inc. 		Kavuru, Vimal
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+45,000 vol 		87,100
Filed 2021-11-15 14:11
Tx date 2021-11-12 		$ACST
Acasti Pharma Inc. 		Kavuru, Vimal
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+42,100 vol 		42,100
Filed 2021-11-15 14:10
Tx date 2021-08-27 		$ACST
Acasti Pharma Inc. 		Kavuru, Vimal
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2021-09-07 09:53
Tx date 2021-08-27 		$ACST
Acasti Pharma Inc. 		Kavuru, Vimal
4 - Director of Issuer
Holder: Kottayil Grace Pharma LLC (Control or Direction)
Common Shares (Actions de catégorie A)
00 - Opening Balance-Initial SEDI Report 		746,064
Filed 2021-09-03 14:24
Tx date 2021-08-27 		$ACST
Acasti Pharma Inc. 		Kavuru, Vimal
4 - Director of Issuer
Holder: Shore Pharma LLC (Indirect Ownership)
Common Shares (Actions de catégorie A)
00 - Opening Balance-Initial SEDI Report 		3,070,229